| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.034 | 0.9 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.03 | 0.9 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.9 |